Lipid-Based Nanoparticulate Systems for the Delivery of Anti-Cancer Drug Cocktails: Implications on Pharmacokinetics and Drug Toxicities

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|10|8|861-874

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.10, Iss.8, 2009-10, pp. : 861-874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid-Based Drug Delivery Systems for Cancer Treatment

By  

Current Drug Targets, Vol. 12, Iss. 8, 2011-07 ,pp. : 1151-1165

Bentham Science Publishers

Access to resources Recommend Favorite

The Formulation of Lipid-Based Nanotechnologies for the Delivery of Fixed Dose Anticancer Drug Combinations

By  

Current Drug Delivery, Vol. 2, Iss. 4, 2005-10 ,pp. : 341-351

Bentham Science Publishers

Access to resources Recommend Favorite

Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment

By  

Current Drug Delivery, Vol. 12, Iss. 2, 2015-04 ,pp. : 177-191

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticulate Drug Delivery Systems

By Senior Judy  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 1, 2008-01 ,pp. : 116-116

Informa Healthcare

Access to resources Recommend Favorite

Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems

By  

Current Drug Delivery, Vol. 10, Iss. 2, 2013-04 ,pp. : 208-240

Bentham Science Publishers

Access to resources Recommend Favorite